ValenTx (Carpenteria, CA) a development-stage medical device company focused on minimally invasive approaches for the treatment of morbid obesity, closed a $20.3M Series B financing. Participants include SV Life Sciences, Covidien Ventures, Sapient Capital, EDF Ventures, Kaiser Permanente Ventures, Affinity Capital and TGap Ventures.